Xencor, Inc.
BISPECIFIC AND MONOSPECIFIC ANTIBODIES USING NOVEL ANTI-PD-1 SEQUENCES
Last updated:
Abstract:
The present invention is directed to bispecific, heterodimeric checkpoint antibodies.
Status:
Application
Type:
Utility
Filling date:
8 Nov 2018
Issue date:
29 Aug 2019